Maravai LifeSciencesMRVI
那斯達克 · USD
6.99
+0.20
(+2.95%)
收盤 10/20 03:59 (UTC+8)
10/20 03:59 (UTC+8)
Maravai LifeSciencesMRVI
6.99
+0.20
(+2.95%)
財務數據
損益表
- 0.64
- 0.73
- 0.65
- 0.57
- 0.47
- 0.47
- 0.42
- 0.50
- 0.66
- 0.51
- -13.44
- 14.37
- -11.17
- -13.25
- -17.16
- 1.17
- -12.17
- 19.78
- 32.03
- -21.86
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 51,442 | 65,837 | 49,866 | 41,630 | 47,397 | 46,850 | 56,558 | 65,200 | 73,400 | 64,179 |
營業成本 | 30,792 | 32,136 | 37,024 | 35,975 | 39,629 | 39,125 | 37,168 | 36,826 | 38,271 | 38,335 |
營業毛利 | 20,650 | 33,701 | 12,842 | 5,655 | 7,768 | 7,725 | 19,390 | 28,374 | 35,129 | 25,844 |
營業費用 | 35,739 | 35,859 | 71,637 | 46,686 | 74,046 | 56,887 | 57,092 | 197,488 | 44,641 | 44,705 |
研發費用 | 3,702 | 3,889 | 3,788 | 3,844 | 4,882 | 4,888 | 4,561 | 4,344 | 5,284 | 5,032 |
推銷及管理費用 | 32,070 | 29,092 | 31,583 | 35,456 | 38,715 | 39,564 | 40,613 | 38,909 | 39,361 | 40,885 |
非經常性項目費用 | -33 | 2,878 | 36,266 | 7,386 | 30,449 | 12,435 | 11,918 | 154,235 | -4 | -1,212 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -15,089 | -2,158 | -58,795 | -41,031 | -66,278 | -49,162 | -37,702 | -169,114 | -9,512 | -18,861 |
其他收入及費用 | -1,904 | 1,379 | 2,341 | 2,726 | -1,032 | 3,249 | 2,891 | 7,104 | 4,524 | 7,316 |
利息費用 | 4,809 | 5,749 | 6,555 | 6,844 | 6,815 | 6,778 | 11,263 | 13,634 | 11,939 | 10,864 |
稅前純益 | -21,802 | -6,528 | -63,009 | -45,149 | -74,125 | -52,691 | -46,074 | -175,644 | -16,927 | -22,409 |
所得稅 | -171 | -151 | 6 | -92 | -4,288 | 162 | -7 | 311 | -2,435 | 271 |
稅後純益 | -12,416 | -3,733 | -35,681 | -25,556 | -39,591 | -29,945 | -25,905 | -99,038 | -7,585 | -12,078 |
基本每股稅後盈餘(元) | -0.08 | -0.02 | -0.24 | -0.18 | -0.27 | -0.21 | -0.18 | -0.70 | -0.05 | -0.09 |
稀釋每股稅後盈餘(元) | -0.09 | -0.02 | -0.24 | -0.18 | -0.27 | -0.21 | -0.18 | -0.72 | -0.06 | -0.09 |
基本平均股數(千股) | 147996.00 | 146426.00 | 145074.00 | 144683.00 | 144236.00 | 143425.00 | 141812.00 | 141555.00 | 135842.00 | 132333.00 |
稀釋平均股數(千股) | 147996.00 | 146426.00 | 145074.00 | 144683.00 | 144236.00 | 143425.00 | 141812.00 | 141555.00 | 135842.00 | 132333.00 |
還原基本每股稅後盈餘(元) | -0.08 | -0.02 | -0.24 | -0.18 | -0.27 | -0.21 | -0.18 | -0.70 | -0.05 | -0.09 |
還原稀釋每股稅後盈餘(元) | -0.09 | -0.02 | -0.24 | -0.18 | -0.27 | -0.21 | -0.18 | -0.72 | -0.06 | -0.09 |
還原基本平均股數(千股) | 147,996 | 146,426 | 145,074 | 144,683 | 144,236 | 143,425 | 141,812 | 141,555 | 135,842 | 132,333 |
還原稀釋平均股數(千股) | 147,996 | 146,426 | 145,074 | 144,683 | 144,236 | 143,425 | 141,812 | 141,555 | 135,842 | 132,333 |
EBITDA(千元) | 5,629 | 14,843 | -13,984 | -2,110 | -20,826 | -7,634 | 535 | -70,300 | 17,210 | 13,550 |